"Fibric Acids" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Compounds that either share the structure of fibric acid in their molecular arrangement or are considered variants of the fibric acid structure.
| Descriptor ID |
D058607
|
| MeSH Number(s) |
D02.241.081.114.968.500 D02.355.726.305 D02.455.426.559.389.657.654.305
|
| Concept/Terms |
Fibric Acids- Fibric Acids
- Methyl-2-Phenoxypropanoic Acid Derivatives
- Methyl 2 Phenoxypropanoic Acid Derivatives
- Fibric Acid Derivatives
- Acid Derivatives, Fibric
- 2-Phenoxy Isobutyric Acids
- 2 Phenoxy Isobutyric Acids
- Isobutyric Acids, 2-Phenoxy
- 2-Phenoxy-2-Methylpropionic Acid Derivatives
- 2 Phenoxy 2 Methylpropionic Acid Derivatives
|
Below are MeSH descriptors whose meaning is more general than "Fibric Acids".
Below are MeSH descriptors whose meaning is more specific than "Fibric Acids".
This graph shows the total number of publications written about "Fibric Acids" by people in this website by year, and whether "Fibric Acids" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 0 | 1 | 1 |
| 2003 | 0 | 1 | 1 |
| 2013 | 0 | 1 | 1 |
| 2015 | 0 | 1 | 1 |
| 2016 | 0 | 1 | 1 |
| 2022 | 1 | 0 | 1 |
| 2023 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Fibric Acids" by people in Profiles.
-
What is really new in triglyceride guidelines? Curr Opin Endocrinol Diabetes Obes. 2023 04 01; 30(2):73-80.
-
The Fibrates Story - A Tepid End to a PROMINENT Drug. N Engl J Med. 2022 11 24; 387(21):1991-1992.
-
Lipid-Modifying Efficacy and Tolerability of Anacetrapib Added to Ongoing Statin Therapy in Patients with Hypercholesterolemia or Low High-Density Lipoprotein Cholesterol. Am J Cardiol. 2017 Feb 01; 119(3):388-396.
-
Treatment of dyslipidemia in HIV. Curr Atheroscler Rep. 2015 Apr; 17(4):493.
-
Impaired lipoprotein processing in HIV patients on antiretroviral therapy: aberrant high-density lipoprotein lipids, stability, and function. Arterioscler Thromb Vasc Biol. 2013 Jul; 33(7):1714-21.
-
Molecular profiling of hepatocellular carcinomas developing spontaneously in acyl-CoA oxidase deficient mice: comparison with liver tumors induced in wild-type mice by a peroxisome proliferator and a genotoxic carcinogen. Carcinogenesis. 2003 May; 24(5):975-84.
-
Antihyperlipidaemic agents. Drug interactions of clinical significance. Drug Saf. 1994 Nov; 11(5):301-9.